MedTrace Logo

Pediatric Type 1 Diabetes and Neurocognitive Complications Cohort Study

NCT04135365 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2022-11-01

No results posted yet for this study

Summary

The proposed project will assess hypothesized risk factors (age of onset, Diabetic ketoacidosis (DKA) at presentation and glycemic control), as well as potentially modifiable protective factors (child sleep quality, caregiver distress, and use of diabetes devices). In addition, the study will optimize imaging protocols and processing tools to allow for harmonization of neuroimaging data across sites and scanners for the most robust analysis.

Conditions

Interventions

BEHAVIORAL

neurocognitive assessment

Observational study therefore there are no interventions

BEHAVIORAL

neuroimaging assessment

Observational study therefore there are no interventions

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Sarah S Jaser, PhD · Vanderbilt University Medical Center

  • Lori Jordan, MD, PhD · Vanderbilt University Medical Center

Eligibility

Min Age
6 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-18
Primary Completion
2022-10-31
Completion
2022-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04135365 on ClinicalTrials.gov